# Ginkgo Bioworks Holdings Inc. (DNA)

Source: https://www.quantisnow.com/company/DNA
Generated: 2026-11-14T11:35:58.259Z

- Ticker: DNA
- Exchange: NYSE
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2021
- SEC CIK: 0001830214
- Website: ginkgobioworks.com

## About

Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is based in Boston, Massachusetts.

## Latest DNA news and filings

- 2026-11-09 21:52 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ginkgo Bioworks Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ginkgo-bioworks-holdings-inc-6781884)
- 2026-11-05 21:07 UTC [SEC Form 8-K] [Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ginkgo-bioworks-holdings-inc-filed-sec-form-8-k-results-of-6776299)
- 2026-11-05 21:05 UTC [Earnings] [Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo](https://www.quantisnow.com/insight/ginkgo-bioworks-reports-third-quarter-2026-results-signs-first-autonomous-6776096)
- 2026-10-29 20:06 UTC [SEC Form 8-K] [SEC Form 8-K filed by Ginkgo Bioworks Holdings Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-ginkgo-bioworks-holdings-inc-6763513)
- 2026-10-21 20:07 UTC [SEC Form 4] [Officer Coen Steven P. sold $7,770 worth of shares (766 units at $10.14) (SEC Form 4)](https://www.quantisnow.com/insight/officer-coen-steven-p-sold-7770-worth-of-shares-766-6753521)
- 2026-10-21 20:06 UTC [SEC Form 4] [Officer Shetty Reshma P. sold $417,608 worth of shares (41,172 units at $10.14) (SEC Form 4)](https://www.quantisnow.com/insight/officer-shetty-reshma-p-sold-417608-worth-of-shares-41172-6753514)
- 2026-10-21 20:06 UTC [SEC Form 4] [Large owner Canton Barry sold $417,608 worth of shares (41,172 units at $10.14) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-canton-barry-sold-417608-worth-of-shares-41172-6753511)
- 2026-10-21 20:05 UTC [SEC Form 4] [Officer Kelly Jason R sold $463,353 worth of shares (45,682 units at $10.14) (SEC Form 4)](https://www.quantisnow.com/insight/officer-kelly-jason-r-sold-463353-worth-of-shares-45682-6753490)
- 2026-10-08 20:10 UTC [Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program](https://www.quantisnow.com/insight/ginkgo-bioworks-to-provide-autonomous-lab-access-to-nsf-x-labs-6741777)
- 2026-10-08 10:00 UTC [Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop](https://www.quantisnow.com/insight/araceli-biosciences-and-ginkgo-bioworks-bring-cellular-imaging-at-scale-6740802)
- 2026-10-07 21:00 UTC [SEC Form 4] [Officer Coen Steven P. sold $36,045 worth of shares (2,403 units at $15.00) (SEC Form 4)](https://www.quantisnow.com/insight/officer-coen-steven-p-sold-36045-worth-of-shares-2403-6740573)
- 2026-09-29 12:00 UTC [Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium](https://www.quantisnow.com/insight/ginkgo-datapoints-and-apheris-welcome-abbvie-argenx-lundbeck-and-takeda-6728574)
- 2026-09-16 20:06 UTC [SEC Form 4] [Director Henry Christian O sold $35,405 worth of shares (5,000 units at $7.08), decreasing direct ownership by 21% to 19,310 units (SEC Form 4)](https://www.quantisnow.com/insight/director-henry-christian-o-sold-35405-worth-of-shares-5000-6717502)
- 2026-09-16 13:52 UTC [Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data](https://www.quantisnow.com/insight/ginkgo-datapoints-announces-partnership-with-tunelab-to-close-the-gap-6717188)
- 2026-09-15 15:47 UTC [SEC Form 144] [SEC Form 144 filed by Ginkgo Bioworks Holdings Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-ginkgo-bioworks-holdings-inc-6715801)
- 2026-09-10 12:00 UTC [Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines](https://www.quantisnow.com/insight/ginkgo-bioworks-joins-arpa-h-give-program-to-build-autonomous-manufacturing-6710899)
- 2026-08-25 21:01 UTC [SEC Form 4] [Officer Coen Steven P. converted options into 743 shares and sold $2,302 worth of shares (330 units at $6.98), increasing direct ownership by 0.80% to 51,851 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/officer-coen-steven-p-converted-options-into-743-shares-and-6694551)
- 2026-08-07 12:22 UTC [Analyst Downgrade] [Ginkgo Bioworks downgraded by TD Cowen with a new price target](https://www.quantisnow.com/insight/ginkgo-bioworks-downgraded-by-td-cowen-with-a-new-price-6670712)
- 2026-08-06 20:09 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ginkgo Bioworks Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ginkgo-bioworks-holdings-inc-6669011)
- 2026-08-05 20:06 UTC [SEC Form 8-K] [Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ginkgo-bioworks-holdings-inc-filed-sec-form-8-k-results-of-6665142)
- 2026-07-30 20:28 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Canton Barry](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-canton-barry-6656358)
- 2026-07-30 20:27 UTC [SEC Form 4] [SEC Form 4 filed by Officer Shetty Reshma P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-officer-shetty-reshma-p-6656354)
- 2026-07-30 20:26 UTC [SEC Form 4] [SEC Form 4 filed by Officer Kelly Jason R](https://www.quantisnow.com/insight/sec-form-4-filed-by-officer-kelly-jason-r-6656344)
- 2026-07-30 20:06 UTC [SEC Form 8-K] [Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ginkgo-bioworks-holdings-inc-filed-sec-form-8-k-regulation-fd-6656035)
- 2026-07-20 21:00 UTC [SEC Form 4] [Officer Coen Steven P. converted options into 1,486 shares and sold $5,943 worth of shares (752 units at $7.90), increasing direct ownership by 1% to 51,438 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/officer-coen-steven-p-converted-options-into-1486-shares-and-6642703)
- 2026-06-15 21:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Henry Christian O](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-henry-christian-o-6603134)
- 2026-06-15 21:04 UTC [SEC Form 4] [SEC Form 4 filed by Director Fubini Ross](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-fubini-ross-6603128)
- 2026-06-15 21:03 UTC [SEC Form 4] [SEC Form 4 filed by Director Kosuri Sri](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-kosuri-sri-6603121)
- 2026-06-15 21:02 UTC [SEC Form 4] [SEC Form 4 filed by Director Sloan Harry](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-sloan-harry-6603116)
- 2026-06-12 21:00 UTC [SEC Form 8-K] [Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/ginkgo-bioworks-holdings-inc-filed-sec-form-8-k-submission-of-6600956)
- 2026-05-26 21:04 UTC [SEC Form 4] [Officer Coen Steven P. converted options into 743 shares and sold $2,559 worth of shares (307 units at $8.33), increasing direct ownership by 0.87% to 50,704 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/officer-coen-steven-p-converted-options-into-743-shares-and-6572904)
- 2026-05-26 16:33 UTC [Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery](https://www.quantisnow.com/insight/ginkgo-datapoints-tangible-scientific-and-inductive-bio-launch-adme-one-a-6571776)
- 2026-05-15 21:48 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Ginkgo Bioworks Holdings Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-ginkgo-bioworks-holdings-6558564)
- 2026-05-12 14:30 UTC [The $59B Quiet Shift Reshaping How Patients Access Care](https://www.quantisnow.com/insight/the-59b-quiet-shift-reshaping-how-patients-access-care-6547270)
- 2026-05-07 20:13 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ginkgo Bioworks Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ginkgo-bioworks-holdings-inc-6539430)
- 2026-05-07 20:09 UTC [SEC Form 8-K] [Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ginkgo-bioworks-holdings-inc-filed-sec-form-8-k-results-of-6539070)
- 2026-05-07 20:05 UTC [Earnings Date] [Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab](https://www.quantisnow.com/insight/ginkgo-bioworks-reports-first-quarter-2026-financial-results-completes-divestiture-6538817)
- 2026-04-30 12:01 UTC [Earnings Date] [Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation](https://www.quantisnow.com/insight/ginkgo-bioworks-announces-date-of-first-quarter-2026-results-presentation-6523016)
- 2026-04-29 20:14 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Ginkgo Bioworks Holdings Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-ginkgo-bioworks-holdings-inc-6521324)
- 2026-04-29 20:10 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Ginkgo Bioworks Holdings Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-ginkgo-bioworks-holdings-inc-6521263)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/DNA
- Earnings history: https://www.quantisnow.com/earnings/DNA
- Dividend history: https://www.quantisnow.com/dividends/DNA
- Insider transactions: https://www.quantisnow.com/insiders/DNA
- Options chain: https://www.quantisnow.com/options/DNA
- SEC 8-K filings only: https://www.quantisnow.com/company/DNA/8-k
- RSS and alerts for DNA: https://www.quantisnow.com/docs/rss-feeds.md